PerMe

PerMe offers the world's first instant, lab-free DNA test, delivering results directly to your phone.

Health Tech & Life Sciences
Active
Pre-Seed Herzliya, Israel Founded 2020
Last updated 2026-07-20
Total raised
Last: Undisclosed Round 2025-01
Stage
Pre-Seed
Founded
2020
Headcount
14
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

PerMe is a deep tech-based digital health platform focusing on DNA tests, aiming to make personalized health accessible. The company offers a simple, cheap, and fast single-use sensor that identifies genetic variations and provides digital results within minutes directly to the mobile phone without needing microelectronic components or a laboratory. The platform converts biological data into health recommendations. PerMe is driven by a team of experienced entrepreneurs and seeks to make DNA-based health solutions accessible to everyone. The company's innovative technology democratizes DNA testing, making personalized healthcare for disease detection, beauty, supplements, medication, pet care, sexual health recommendations, microbiome and age-related analysis, and Telehealth consultations accessible to all. Applying advanced data analytics and AI/ML on the big data collected will be the heart of healthcare innovation, understanding complex diseases and discovering new medicines.

Funding history · 2 rounds · — total

2024-12
Seed Undisclosed
★ Rhodium
2024-08
Pre-Seed Undisclosed
★ IL Angel Club

Headcount over time

From 14 (2024-03) to 17 (2025-12) · +3 (+21%) · 2 points · source: Finder history + radar grounding
170 2024-03 2025-12

Q&A

What is PerMe's primary focus?
PerMe is a deep-tech digital health platform that develops disruptive innovation in home DNA testing, converting biological samples to digital information in real-time with an affordable device that does not require labs.
When was PerMe founded?
PerMe was founded in May 2022.
Who are the founders of PerMe?
The founders of PerMe are Yoav Rapaport (Founder & CEO) and Igal Chertkow (Founder & CTO).
What is PerMe's current funding stage?
PerMe is currently in the Pre-Seed funding stage.
Which investors participated in PerMe's January 2025 funding round?
Rhodium participated in PerMe's funding round in January 2025.
Which investors participated in PerMe's September 2024 funding round?
IL Angel Club participated in PerMe's funding round in September 2024.
What technologies does PerMe utilize in its platform?
PerMe utilizes Artificial Intelligence and Machine Learning in its platform.

Team · 2

Yoav Rapaport
Founder · CEO
Igal Chertkow
Founder · CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Tags

testingdigital-healthcarebiotechnologyremote-monitoring
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepermedna.com/
LinkedInlinkedin.com/company/88676302

Identifiers & details

Legal namePerMe DNA
Founded2020
Employees (exact)14

Radar intelligence

Patents

EPO2

Publications (Crossref)

Works8

Web history (Wayback)

Domainpermedna.com

Certificate / subdomain footprint

Subdomains5